Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Timothy R. Abbott, Girija Dhamdhere, Yanxia Liu, Xueqiu Lin, Laine Goudy, Leiping Zeng, Augustine Chemparathy, Steven A. Chmura, Nicholas S. Heaton, Robert J. Debs, Tara Pande, Drew Endy, Marie La Russa, David B. Lewis, Lei S. Qi
Topics & Concepts
CRISPRBiologyVirologyVirusCoronavirusPandemicInfluenza A virusCoronavirus disease 2019 (COVID-19)Computational biologyDiseaseInfectious disease (medical specialty)GeneticsGeneMedicinePathologyCRISPR and Genetic EngineeringSARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology Research